Search for: "Novartis Ag" Results 201 - 220 of 440
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Jul 2013, 5:38 pm by Submitted Posting
Lipimile, Director & Chief Executive Officer, COMESA Competition Commission • Ali Haddou Ruiz, Executive Secretary, The Federal Competition Commission, Mexico • Michele Piergiovanni, Case Manager, European Commission Merger Control Unit, European Commission • Carel Maske, Senior Attorney, Antitrust, Microsoft EMEA • Martin Commons, Senior Competition/Antitrust Counsel, BHP Billiton • Joerg Haering, Division General Counsel Legal & Compliance, Siemens • Susan… [read post]
26 Jun 2013, 6:43 am
It is therefore insufficient: see Novartis AG v Johnson & Johnson Medical Ltd [2010] EWCA Civ 1039, [2011] ECC 10 at [77]. [read post]
14 May 2013, 3:10 pm by Angel Reyes
  Major brand names of these medications include Novartis, Pfizer, Triaminic, Dimetapp and Robitussin. [read post]
7 May 2013, 8:53 am
This was explained by Kitchin J in Novartis AG v Johnson & Johnson Medical Ltd [2009] EWHC 1671 (Pat) at [122] as follows, having cited a passage from G2/98: “I discern from this passage that the EPO considers it is permissible to afford different priority dates to different parts of a patent claim where those parts represent a limited number of clearly defined alternative subject-matters and those alternative subject-matters have been disclosed (and are enabled) by… [read post]
5 May 2013, 11:10 am
A new lawsuit suggests that it wasn't for Big Pharma player Novartis AG—the company was charged last month with fraud, allegedly for paying kickbacks to pharmacies that switched transplant patients from a less expensive generic drug to to its brand name med, Myfortic. [read post]
28 Apr 2013, 9:32 am by Ben Vernia
* * * The following allegations are based on the government’s complaint filed in the Southern District of New York: Novartis, a pharmaceutical company headquartered in East Hanover, N.J., is a subsidiary of Novartis AG, an international pharmaceutical company headquartered in Basel, Switzerland. [read post]
25 Apr 2013, 5:02 pm
Plaintiff Dottie Dodson is suing Novartis AG for dangerous drug injury compensation. [read post]
25 Apr 2013, 4:24 am by Heidi Henson
“The U.S. is seeing a dynamic of an aging population and a dramatic increase in diversity among new voters and workers,” added Visconti. [read post]
22 Apr 2013, 5:34 am by Rebecca Tushnet
At the same time, he said that Endometrin “was not found to be efficacious for women over the age of 35. [read post]
11 Apr 2013, 8:10 am by Jason Rantanen
  References a threat that Novartis made to block the sale of future drugs in India. [read post]
7 Apr 2013, 9:37 pm by Patent Docs
Noven Pharmaceuticals Inc. et al. 1:13-cv-00527; filed April 3, 2013 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG; Novartis Pharma AG; Novartis International Pharmaceutical Ltd.; LTS Lohmann Therapie-Systeme AG • Defendants: Noven Pharmaceuticals Inc.; Noven Therapeutics LLC; Hisamitsu Pharmaceutical Co. [read post]
2 Apr 2013, 12:44 pm by Jack McNeill
In a case that may have world-wide ramifications the Supreme Court of India has ruled in Novartis AG v. [read post]
2 Apr 2013, 7:43 am by Simon Lester
In a case closely watched by global drugmakers, Switzerland’s Novartis AG has been fighting since 2006 to patent its leukemia-treating drug Glivec in India on the grounds that it is a newer version. [read post]
31 Mar 2013, 9:32 pm by Patent Docs
UK Patent No. 2,203,040 to Novartis AG (and the associated Supplementary Protection Certificate (SPC)) protected rivastigmine, a drug used for the treatment of Alzheimer's disease. [read post]
7 Mar 2013, 11:06 am by Erin F. Siegfried
Novartis AG and UBS AG are two of the multinational companies listed in Switzerland that will be affected by the Minder proposals. [read post]
18 Feb 2013, 5:48 am
You can also get in touch with Novartis for information about a refund. [read post]
9 Feb 2013, 4:04 pm by Larry Catá Backer
  These statements can also be accessed via the government websites of the countries concerned.Argentina / ArgentineUnión Obrera Molinera and Cargill S.A. specific instance: Statement by the Argentinian NCP, 31 July 2007Australia / AustraliePublic statement by the Australian NCP on the transfer of a specific instance involving an Australian-headquartered enterprise to the Chilean NCP, 1 March 2012 Public statement by the Australian NCP on the transfer of a specific… [read post]